A new report shows that Ireland attracted fewer industry-sponsored interventional clinical trials than both Finland and Denmark between 2014 and 2023, despite all three countries having a similar population size and economic wealth.
Key players active in Ireland’s clinical trials arena want the government to come up with a national strategy to stop the continuing decline of industry sponsored interventional trials in the country, which currently lags behind its European peers in attracting trial sponsors.
Calls for reforming Ireland’s clinical trial processes were made at a webinar organized on 11 June by the Irish Pharmaceutical...
<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>
As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.
<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>
A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.
With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.
